a 2016

No improvement in long-term overal survival after the introduction of chemo(immuno)therapy for chronic lymphocytic leukemia patients belonging to stereotyped subsets 2.

BALIAKAS, P.; M. MATTSSON; A. HADZIDIMITRIOU; E. MINGA; A. AGATHANGELIDIS et. al.

Basic information

Original name

No improvement in long-term overal survival after the introduction of chemo(immuno)therapy for chronic lymphocytic leukemia patients belonging to stereotyped subsets 2.

Authors

BALIAKAS, P.; M. MATTSSON; A. HADZIDIMITRIOU; E. MINGA; A. AGATHANGELIDIS; LA. SUTTON; L. SCARFO; Z. DAVIS; XJ. YAN; Karla PLEVOVÁ; Y. SANDBERG; F. JUHL VOJDEMAN; T. TZENOU; CC. CHU; S. VERONEZE; L. MANSOURI; KE. SMEDBY; V. GIUDICELLI; F. NGUYEN KHAC; P. PANAGIOTIDIS; G. JULIUSSON; A. ANAGNOSTOPOULOS; MP. LEFRANC; L. TRENTIN; M. CATHERWOOD; M. MONTILLO; CU. NIEMANN; AW. LANGERAK; Šárka POSPÍŠILOVÁ; N. STAVROYIANNI; N. CHIORAZZI; D. OSCIER; D. JELINEK; T. SHANAFELT; Nikos DARZENTAS; C. BELESSI; F. DAVI; P. GHIA; R. ROSENQUIST and K. STAMATOPOULOS

Edition

Haematologica (2016); 101(s1): 231 (21st Congress of the EHA), 2016

Other information

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Central European Institute of Technology
Changed: 7/12/2016 14:14, Bc. Kateřina Kolesová